Oscar Health, Inc. (OSCR) stock plummeted 15.77% in Tuesday's trading session after the health insurer reported worse-than-expected fourth quarter earnings results and provided underwhelming full-year 2025 revenue guidance.
For the fourth quarter of 2024, Oscar Health posted an earnings per share loss of $0.62, wider than the consensus analyst estimate of $0.58 per share. The company's revenue for the quarter came in at $2.39 billion, missing expectations of $2.47 billion. Higher medical costs were cited as a key factor behind the earnings miss.
Looking ahead, Oscar Health's full-year 2025 revenue guidance of $11.2-11.3 billion fell short of the consensus estimate of $11.69 billion, raising concerns among investors about the company's growth prospects. The disappointing guidance overshadowed the company's forecast for a return to profitability in 2025, with expected earnings from operations between $225-275 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.